Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciro Manzo

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Clinical and Experimental Rheumatology|February 26, 2021
Calcium pyrophosphate disease and polymyalgia reumatica: association or coincidence? Comment on "Ultrasound shoulder assessment of calcium pyrophosphate disease with suspected polymyalgia rheumatica" Ottaviani et alMarcin Milchert, Ciro Manzo, Alberto Castagna, et al.
Medical Sciences (Basel, Switzerland)|April 23, 2025
Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case ReportsCiro Manzo, Marco Isetta, Alberto Castagna, et al.
Recenti Progressi in Medicina|April 12, 2017
[Macrocytosis of red blood cells and early arthritis positive for rheumatoid factor such as initial manifestations of a neuroendocrine gastrin-secreting gastric tumor.]Ciro Manzo, Maria Natale, Gennaro Mossetti, et al.
Joint Bone Spine|October 3, 2021
Answer to Cadiou et al. "SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?". Joint Bone Spine 2021;88:105282Ciro Manzo, Alberto Castagna, Maria Natale, et al.
Reumatologia|November 16, 2023
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months updateCiro Manzo, Alberto Castagna, Arvind Nune, et al.
Reumatologia|February 7, 2024
Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumaticaCiro Manzo, Alberto Castagna, Nicola Veronese, et al.
Balkan Medical Journal|July 25, 2022
Post-COVID-19 Condition and İts Recognition in Low- and Middle-income Countries: Working Notes from the United Kingdom ExperienceArvind Nune, Karthikeyan P Iyengar, Bhupen Barman, et al.
Medical Hypotheses|January 10, 2021
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, et al.
Medicines (Basel, Switzerland)|August 4, 2018
Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with GlucocorticoidsCiro Manzo, Jordi Serra-Mestres, Alberto Castagna, et al.
Clinical Rheumatology|May 16, 2022
The VEXAS syndrome from rheumatology perspective: genomic DNA sequencing as available blueprint for diagnosing rheumatic diseases with overlapping haematological or dermatological findingsArvind Nune, Karthikeyan P Iyengar, Bhupen Barman, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Clinical and Experimental Rheumatology|February 26, 2021
Calcium pyrophosphate disease and polymyalgia reumatica: association or coincidence? Comment on "Ultrasound shoulder assessment of calcium pyrophosphate disease with suspected polymyalgia rheumatica" Ottaviani et alMarcin Milchert, Ciro Manzo, Alberto Castagna, et al.
Medical Sciences (Basel, Switzerland)|April 23, 2025
Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case ReportsCiro Manzo, Marco Isetta, Alberto Castagna, et al.
Recenti Progressi in Medicina|April 12, 2017
[Macrocytosis of red blood cells and early arthritis positive for rheumatoid factor such as initial manifestations of a neuroendocrine gastrin-secreting gastric tumor.]Ciro Manzo, Maria Natale, Gennaro Mossetti, et al.
Joint Bone Spine|October 3, 2021
Answer to Cadiou et al. "SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?". Joint Bone Spine 2021;88:105282Ciro Manzo, Alberto Castagna, Maria Natale, et al.
Reumatologia|November 16, 2023
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months updateCiro Manzo, Alberto Castagna, Arvind Nune, et al.
Reumatologia|February 7, 2024
Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumaticaCiro Manzo, Alberto Castagna, Nicola Veronese, et al.
Balkan Medical Journal|July 25, 2022
Post-COVID-19 Condition and İts Recognition in Low- and Middle-income Countries: Working Notes from the United Kingdom ExperienceArvind Nune, Karthikeyan P Iyengar, Bhupen Barman, et al.
Medical Hypotheses|January 10, 2021
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, et al.
Medicines (Basel, Switzerland)|August 4, 2018
Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with GlucocorticoidsCiro Manzo, Jordi Serra-Mestres, Alberto Castagna, et al.
Clinical Rheumatology|May 16, 2022
The VEXAS syndrome from rheumatology perspective: genomic DNA sequencing as available blueprint for diagnosing rheumatic diseases with overlapping haematological or dermatological findingsArvind Nune, Karthikeyan P Iyengar, Bhupen Barman, et al.
Pageof 9